19.07.2013 Views

changes in protein profiles in bortezomib applied multiple myeloma ...

changes in protein profiles in bortezomib applied multiple myeloma ...

changes in protein profiles in bortezomib applied multiple myeloma ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3.2.5. Cell Proliferation Assay<br />

Anti-proliferative effects of Bortezomib on U-266 MM cells were determ<strong>in</strong>ed by<br />

XTT cell proliferation assay. The pr<strong>in</strong>ciple of this assay is based on the ability of<br />

metabolic active cells to reduce the tetrazolium salt XTT to orange colored compounds<br />

of formazan by their mitochondrial enzyme. These formazan molecules formed is water<br />

soluble and can be measurable at the wavelength of 492 nm with a spectrophotometer.<br />

Briefly, the test procedure <strong>in</strong>cludes cultivation of cells <strong>in</strong> a 96-well plate, add<strong>in</strong>g<br />

the XTT reagent (The procedure for preparation of XTT Reaction Solution that was<br />

used <strong>in</strong> XTT Assay was given <strong>in</strong> Appendix B) and <strong>in</strong>cubation for 72 hours. Dur<strong>in</strong>g<br />

<strong>in</strong>cubation an orange color is formed. The greater the number of the active cells <strong>in</strong> the<br />

well, the greater the activity of mitochondria enzymes and the higher the concentration<br />

of the formazan compounds (dye) formed, which can then be measured and quantitated<br />

with a spectrophotometer.<br />

2x10 4 U-266 cells (100 µl) were seeded <strong>in</strong>to 96-well plates conta<strong>in</strong><strong>in</strong>g 200 µl<br />

growth medium <strong>in</strong> the absence or presence of <strong>in</strong>creas<strong>in</strong>g concentrations of Bortezomib<br />

(Figure 3.1)<br />

C C<br />

C C<br />

0.1<br />

0.1<br />

0.1 0.1<br />

C C 0.1 0.1 1<br />

C C 0.1 0.1<br />

C C<br />

C C<br />

0.1<br />

0.1<br />

0.1<br />

1<br />

1<br />

1<br />

1<br />

BLANK<br />

1 5 5<br />

1 5<br />

0.1 1 1 5<br />

1<br />

1<br />

1<br />

BLANK<br />

96 Well Plate A<br />

Figure 3.1. The Dosage of Bortezomib (nM) Applied on MM U-266 Cells<br />

5<br />

5<br />

5<br />

5<br />

5<br />

5 5<br />

10<br />

10<br />

10<br />

10<br />

10<br />

5 10<br />

10<br />

10<br />

10<br />

10<br />

a0<br />

10<br />

20<br />

20<br />

20 20<br />

20<br />

20<br />

20<br />

20<br />

20<br />

20<br />

10 20 20<br />

(cont. on next page)<br />

48

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!